Literature DB >> 7556959

Treatment with insulin-like growth factor I alters capillary permeability in skin and retina.

M A Hussain1, K Studer, E P Messmer, E R Froesch.   

Abstract

Treatment with insulin-like growth factor I (IGF-I) is accompanied by mild generalized and reversible edema. These changes may be due to increased capillary permeability. Therefore, we studied the effects of subcutaneous IGF-I treatment in healthy subjects on capillary permeability of the skin and the retina. Eight healthy subjects were treated with saline or recombinant human IGF-I (rhIGF-I) (10 micrograms.kg-1.h-1 s.c.) in a randomized crossover fashion. Transcapillary diffusion of sodium fluorescein (NaF) was quantitated by video densitometry in the skin in all subjects on the 4th treatment day. In seven subjects, plasma penetration of NaF at the blood-retinal barrier was investigated using vitreous fluorometry (VF) on days 3 and 5. Fluorescent light intensities of the skin and plasma penetration determined by VF were significantly higher during the IGF-I treatment as compared with those during the control situation. In conclusion, IGF-I treatment at the above dose is accompanied by increased transcapillary diffusion of NaF in skin and in retinal vessels.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7556959     DOI: 10.2337/diab.44.10.1209

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  9 in total

Review 1.  Macular oedema: the role of soluble mediators.

Authors:  D Kent; S A Vinores; P A Campochiaro
Journal:  Br J Ophthalmol       Date:  2000-05       Impact factor: 4.638

2.  Evaluation of macular and peripapillary choroidal thickness, macular volume and retinal nerve fiber layer in acromegaly patients.

Authors:  Serpil Yazgan; Dilek Arpaci; Haci Ugur Celik; Irem Isik
Journal:  Int Ophthalmol       Date:  2017-05-15       Impact factor: 2.031

3.  Chorio-retinal thickness measurements in patients with acromegaly.

Authors:  G Pekel; F Akin; M S Ertürk; S Acer; R Yagci; M C Hıraali; E N Cetin
Journal:  Eye (Lond)       Date:  2014-09-19       Impact factor: 3.775

4.  Symptomatic cerebral oedema during treatment of diabetic ketoacidosis: effect of adjuvant octreotide infusion.

Authors:  Ora Seewi; Anne Vierzig; Bernhard Roth; Eckhard Schönau
Journal:  Diabetol Metab Syndr       Date:  2010-08-19       Impact factor: 3.320

5.  Evidence that upregulation of serum IGF-1 concentration can trigger acceleration of diabetic retinopathy.

Authors:  E Chantelau
Journal:  Br J Ophthalmol       Date:  1998-07       Impact factor: 4.638

Review 6.  Estrogen-IGF-1 interactions in neuroprotection: ischemic stroke as a case study.

Authors:  Farida Sohrabji
Journal:  Front Neuroendocrinol       Date:  2014-05-29       Impact factor: 8.606

7.  Insulin-Like Growth Factor (IGF)-I Modulates Endothelial Blood-Brain Barrier Function in Ischemic Middle-Aged Female Rats.

Authors:  Shameena Bake; Andre K Okoreeh; Robert C Alaniz; Farida Sohrabji
Journal:  Endocrinology       Date:  2015-11-10       Impact factor: 4.736

8.  The effect of IGF-1 plasma concentration on COVID-19 severity.

Authors:  Ebrahim Hazrati; Mohammad Gholami; Ramin Hamidi Farahani; Khodayar Ghorban; Morteza Ghayomzadeh; Negin Hosseini Rouzbahani
Journal:  Microb Pathog       Date:  2022-01-26       Impact factor: 3.738

Review 9.  Insulin-Like Growth Factor-1 Signaling in Lung Development and Inflammatory Lung Diseases.

Authors:  Zheng Wang; Wenting Li; Qiongya Guo; Yuming Wang; Lijun Ma; Xiaoju Zhang
Journal:  Biomed Res Int       Date:  2018-06-19       Impact factor: 3.411

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.